Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Palvella Therapeutics, Inc. (PVLA) had Stock-Based Compensation of $6.40M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-41.72M |
|
-- |
|
-- |
|
$38.60M |
|
$-38.60M |
|
$-3.11M |
|
$-41.72M |
|
$-41.72M |
|
$-41.72M |
|
$-41.72M |
|
$-41.72M |
|
$-41.72M |
|
$-38.60M |
|
$-38.60M |
|
11.25M |
|
11.25M |
|
$-3.71 |
|
$-3.71 |
|
| Balance Sheet Financials | |
$58.99M |
|
-- |
|
$0.57M |
|
$59.56M |
|
$11.34M |
|
-- |
|
$20.23M |
|
$31.58M |
|
$27.98M |
|
$27.98M |
|
$27.98M |
|
12.38M |
|
| Cash Flow Statement Financials | |
$-25.01M |
|
-- |
|
$-0.66M |
|
$83.60M |
|
$57.98M |
|
$-25.62M |
|
|
Stock-Based Compensation |
$6.40M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.20 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-25.01M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-149.07% |
|
-149.07% |
|
-70.04% |
|
-149.07% |
|
$2.26 |
|
$-2.22 |
|
$-2.22 |
|